Literature DB >> 15646796

Tyrosinase inhibitors isolated from the edible brown alga Ecklonia stolonifera.

Hye Sook Kang1, Hyung Rak Kim, Dae Seok Byun, Byeng Wha Son, Taek Jeong Nam, Jae Sue Choi.   

Abstract

Extracts from seventeen seaweeds were determined for tyrosinase inhibitory activity using mushroom tyrosinase with L-tyrosine as a substrate. Only one of them, Ecklonia stolonifera OKAMURA (Laminariaceae) belonging to brown algae, showed high tyrosinase inhibitory activity. Bioassay-guided fractionation of the active ethyl acetate (EtOAc) soluble fraction from the methanolic extract of E. stolonifera, led us to the isolation of phloroglucinol derivatives [phloroglucinol (1), eckstolonol (2), eckol (3), phlorofucofuroeckol A (4), and dieckol (5)]. Compounds 1 approximately 5 were found to inhibit the oxidation of L-tyrosine catalyzed by mushroom tyrosinase with IC50 values of 92.8, 126, 33.2, 177, and 2.16 microg/mL, respectively. It was compared with those of kojic acid and arbutin, well-known tyrosinase inhibitors, with IC50 values of 6.32 and 112 microg/ mL, respectively. The inhibitory kinetics analyzed from Lineweaver-Burk plots, showed compounds 1 and 2 to be competitive inhibitors with Ki of 2.3x10(-4) and 3.1x10(-4) M, and compounds 3 approximately 5 to be noncompetitive inhibitors with Ki of 1.9x10(-5), 1.4x10(-3) and 1.5x10(-5) M, respectively. This work showed that phloroglucinol derivatives, natural compounds found in brown algae, could be involved in the control of pigmentation in plants and other organisms through inhibition of tyrosinase activity using L-tyrosine as a substrate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15646796     DOI: 10.1007/BF02975886

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  22 in total

Review 1.  Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship.

Authors:  Jakub Gębalski; Filip Graczyk; Daniel Załuski
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice.

Authors:  Kunihisa Iwai
Journal:  Plant Foods Hum Nutr       Date:  2008-12       Impact factor: 3.921

3.  Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes.

Authors:  Ginnae Ahn; Insun Hwang; Eunjin Park; Jinhe Kim; You-Jin Jeon; Jehee Lee; Jae Woo Park; Youngheun Jee
Journal:  Mar Biotechnol (NY)       Date:  2008-01-03       Impact factor: 3.619

4.  Inhibitory effects of Ecklonia cava extract on high glucose-induced hepatic stellate cell activation.

Authors:  Kumiko Yokogawa; Isao Matsui-Yuasa; Akiko Tamura; Masaki Terada; Akiko Kojima-Yuasa
Journal:  Mar Drugs       Date:  2011-12-20       Impact factor: 6.085

5.  Protective Effects of Ecklonia stolonifera Extract on Ethanol-Induced Fatty Liver in Rats.

Authors:  Chae-Young Bang; Jae-Hyuk Byun; Hye-Kyung Choi; Jae-Sue Choi; Se-Young Choung
Journal:  Biomol Ther (Seoul)       Date:  2016-11-01       Impact factor: 4.634

Review 6.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

Review 7.  The hunt for natural skin whitening agents.

Authors:  Nico Smit; Jana Vicanova; Stan Pavel
Journal:  Int J Mol Sci       Date:  2009-12-10       Impact factor: 6.208

Review 8.  Anti-Pigmentary Natural Compounds and Their Mode of Action.

Authors:  Kyuri Kim; YoonJung Huh; Kyung-Min Lim
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

Review 9.  Beneficial effects of marine algal compounds in cosmeceuticals.

Authors:  Noel Vinay Thomas; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2013-01-14       Impact factor: 5.118

10.  Evaluation of the Antioxidant Activities and Tyrosinase Inhibitory Property from Mycelium Culture Extracts.

Authors:  Ki Moon Park; Kyung Min Kwon; Seung Ho Lee
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.